Hmm. so where is our ANN?
Who is buying this morning? Is it current holders, or people with SUD on a watchlist?
It's great news. I particularly like, " As such, we expect to see regulatory clearance in at least one market in the coming year."
If so, I wonder which market and what that will mean in terms of sales and income.
Aytu BioScience Announces ZolpiMist Global Distribution Agreement with SUDA Pharmaceuticals, page-13
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
